Goyal Ajesh, Ghoshal Uday C, Ahamad Imran, Roy Raja, Srivastava Deepakshi, Mohindra Samir, Saraswat Vivek A, Khetrapal C L
Trop Gastroenterol. 2013 Jul-Sep;34(3):136-43. doi: 10.7869/tg.117.
Cirrhosis with portal hypertension (PHT) may be associated with increased small intestinal permeability (SIP), predisposing to malnutrition and bacterial translocation causing septicaemia, endotoxaemia and spontaneous bacterial peritonitis. However, data on SIP in extrahepatic portal venous obstruction (EHPVO), in which PHT occurs without hepatic dysfunction, are scanty. Such studies would help to know the effect of PHT on SIP independent of hepatic dysfunction; hence, we undertook this study.
A total of 96 patients with PHT (cirrhosis 71, EHPVO 25) underwent evaluation of SIP using urinary lactulose/mannitol excretion ratio over 6 hours after oral administration of 15 mL (10 g) lactulose and 5 g mannitol using 1H-NMR spectroscopy by a method described by us previously.
Gender of patients with EHPVO and cirrhosis was comparable but patients with EHPVO were younger in age. The causes of cirrhosis were cryptogenic (n = 22), alcohol (n = 20), post-viral (n = 21) and others (n = 8). Twenty-seven (38%) patients with cirrhosis had ascites. Abnormal SIP was detected in 47 (49%) patients (40/71,56% with cirrhosis vs. 7/25, 28% with EHPVO, p = 0.01). Patients with cirrhosis had a higher urinary lactulose/mannitol excretion ratio than those with EHPVO (0.09, range 0-0.87 mmol vs. 0.05, 0-0.19 mmol; p = 0.008). Patients with abnormal SIP had a higher Child score, and more often had cirrhosis than EHPVO, ascites and deranged liver function. On multivariate analysis, presence of cirrhosis, ascites, high serum bilirubin level and prothrombin time were associated with abnormal SIP.
Cirrhosis was associated with abnormal SIP, which was related to liver dysfunction. However, SIP was normal in patients with EHPVO.
肝硬化伴门静脉高压(PHT)可能与小肠通透性增加(SIP)有关,易导致营养不良和细菌移位,进而引起败血症、内毒素血症和自发性细菌性腹膜炎。然而,关于肝外门静脉阻塞(EHPVO)(即发生门静脉高压但无肝功能障碍)时SIP的数据却很少。此类研究将有助于了解门静脉高压对SIP的影响,而不受肝功能障碍的影响;因此,我们开展了这项研究。
总共96例门静脉高压患者(71例肝硬化患者,25例肝外门静脉阻塞患者),按照我们之前描述的方法,口服15 mL(10 g)乳果糖和5 g甘露醇后,通过1H-NMR光谱法,采用尿乳果糖/甘露醇排泄率评估6小时内的小肠通透性。
肝外门静脉阻塞患者和肝硬化患者的性别相当,但肝外门静脉阻塞患者年龄较小。肝硬化的病因包括隐源性(n = 22)、酒精性(n = 20)、病毒感染后(n = 21)和其他(n = 8)。27例(38%)肝硬化患者有腹水。47例(49%)患者检测到小肠通透性异常(40/71,肝硬化患者中56%;7/25,肝外门静脉阻塞患者中28%,p = 0.01)。肝硬化患者的尿乳果糖/甘露醇排泄率高于肝外门静脉阻塞患者(0.09,范围0 - 0.87 mmol vs. 0.05,0 - 0.19 mmol;p = 0.008)。小肠通透性异常的患者Child评分更高,并比肝外门静脉阻塞患者更常出现肝硬化、腹水和肝功能紊乱。多因素分析显示,肝硬化、腹水、高血清胆红素水平和凝血酶原时间与小肠通透性异常有关。
肝硬化与小肠通透性异常有关,这与肝功能障碍有关。然而,肝外门静脉阻塞患者的小肠通透性正常。